 RICHMOND, Va. LEXINGTON, Ky.--BUSINESS WIRE--Aditxt, Inc. Nasdaq: ADTX, a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with SphereDX, an advanced clinical diagnostic lab focusing on next-generation genomic and metabolomic clinical testing, to offer its AditxtScoreTM for COVID-19. The AditxtScore for COVID-19 is a more comprehensive immune response monitoring tool that tracks multiple combinations of antibody and neutral 